Clinical Trial Update: Cera™ ASD Occluder Post-Market Clinical Follow-Up Study

View source ↗

Summary

This is a post-market clinical follow-up study of the Cera ASD Occluder for atrial septal defect that is currently recruiting to gather longer-term safety and p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Septal Defect

Drugs mentioned

• Cera ASD Occluder

Snippet

Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. | Conditions: Atrial Septal Defect | Status: RECRUITING